| |
|
|
|
Elsevier Business Intelligence, Dublin, Ireland
April 16-18, 2013
Join us in Dublin this Spring and Gain Critical Perspective on the Challenges and Opportunities Facing All Players in the Evolving Global Medical Device MarketElsevier Business Intelligence, publisher of the "The Gray Sheet," IN VIVO, START-UP and Medtech Insight, is pleased to announce Investment In Innovation (IN3) Medical Device 360° Dublin. In today’s increasingly complex, globally driven healthcare environment, your business requires up-to-the-minute market expertise on all the critical factors impacting your success. EBI, as a leader in the field of healthcare industry data and analysis, gives medical technology executives a full 360° view of their market, opportunities and challenges. The upcoming IN3 Medical Device 360° Dublin 2013 conference, which launches EBI’s 12th year of successful and highly anticipated investment and partnering events, is a true reflection of this 360° spirit. Building on the success of past IN³ events in London, Paris, Rome, Brussels, and across the U.S., this must-attend event, being held in the epicenter of the rapidly growing device development and investment community in Ireland, will bring together development- to commercial-stage device start-ups from around the world seeking funding or strategic partnership with top-tier venture capital and strategic decision makers. The two-day conference will also feature international industry experts examining the most pressing issues facing our global industry in 2013 and beyond, via a variety of financing, business development, clinical/regulatory, reimbursement, and emerging market panel discussions and presentations, and networking sessions.
|
|
|
|
|
|
|
|
Organized by:
|
|
Elsevier Business Intelligence |
|
|
Invited Speakers:
|
|
Who Attends? - Presidents, Principals, CEOs, CTOs, COOs, CMOs
- Founders, Board Leaders, Chairpersons
- Venture Partners, Senior Investors, Private Equity, Angel Investors
- VPs/Directors of Strategic Planning, Business Development/Analysis, Marketing, New Technology, Acquisitions, R&D, Sales
From These Types of Companies - Established, large device companies seeking technology via licensing, partnering, and acquisition to broaden or deepen product lines or build sector strength.
- VCs, private equity, investment firms/consultant, and investment banks.
- Medical device, biopharmaceutical, biotech, or other company executives seeking investments or partnerships.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
To be updated
|
|
|
|
|
|
|
|
Registration:
|
|
IN3 Dealmaker's Value Package (Best Value!) - Fees include: - Two room nights (incl. taxes) at The Shelbourne Dublin between April 16-18, 2013 only
- Entrance to all sessions.
- Admission to two cocktail receptions and all breakfasts/lunches/breaks.
- Conference materials, proceedings booklet, and copies of presentation slides, as permitted by our speakers.
- Use of Partnering Software.
- Your company/attendee profile published in Partnering Software and in conference materials.
- 15% off any Elsevier Business Intelligence products purchased at the event.
- And much more!
To register for the IN3 Dealmaker's Value Package ($1995), click here. | Regular Attendee Pricing includes: - All the same features as the Dealmaker's Package, but does not include the 2 night hotel stay.
To register for only IN3 Dublin Regular Attendee (Single Attendee: $1695, Addl. Attendee: $1595), please select your company from the drop-down list below and click Submit. | IN3 Conference Past Attendee Discount*: - All the same features as the Dealmaker's Package, but does not include the 2 night hotel stay.
To register with the IN3 Conference Past Attendee Discount* ($1495), click here.
*Must have attended a previous IN3 Conference in order to receive the special discount. | To register for IN3 Dublin One-Day Pass, click: April 16th ($1395) • April 17th ($1395) • April 18th ($1395) | Click Here to view full pricing schedule. Please note our conference cancellation policy: The last day to cancel your registration for a refund, minus a $300 processing fee, is March 25. After that, you may send another delegate from your company. |
|
|
|
E-mail:
|
|
k.kennedy@elsevier.com
|
|
|
|
|
|
|
|
|